Colossal Biosciences Raises $200M in Series C
Colossal Biosciences has successfully raised $200M in a Series C at a $10.2B valuation led by Breyer Capital, In-Q-Tel, Tony Robbins.
Company Overview
Colossal Biosciences is a Biotech company headquartered in Dallas, TX, founded in 2021 with 150+ employees.
De-extinction and genetic engineering
Fundraising Details
- Amount Raised: $200M
- Round Type: Series C
- Valuation: $10.2B
- Date: 2025-02-10
- Investors: Breyer Capital, In-Q-Tel, Tony Robbins
About Colossal Biosciences
De-extinction and genetic engineering The company is positioned in the Biotech sector, serving a growing market with innovative solutions.
Key Information
- Headquarters: Dallas, TX
- Founded: 2021
- Team Size: 150+
- Industry: Biotech
What This Means
This funding round demonstrates strong investor confidence in Colossal Biosciences's vision and execution. The capital will likely be used to:
- Scale Operations: Expand the team and operational capacity
- Product Development: Enhance existing products and develop new features
- Market Expansion: Enter new markets and strengthen presence in existing ones
- Technology Investment: Invest in infrastructure and technology capabilities
Industry Context
The Biotech sector continues to attract significant investment as companies innovate to meet evolving market demands. Colossal Biosciences's successful fundraising reflects the strong fundamentals and growth potential in this space.
Valuation Milestone
Reaching a $10.2B valuation marks an important milestone for Colossal Biosciences, positioning the company among notable players in the Biotech industry.
Looking Ahead
With this new capital, Colossal Biosciences is well-positioned to execute on its growth strategy and continue building innovative solutions in the Biotech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.
---
This fundraising news was reported on 2025-02-10. For more information about Colossal Biosciences, visit their headquarters at Dallas, TX.